Skip to content

Quality assurance in postoperative pain management by comparing PENG (pericapsular nerve group) blockade and a higher-volume PENG blockade with and without foot-down positioning in patients undergoing total hip arthroplasty (THA) under general anesthesia with lateral access, and a high-volume and low-concentration femoral nerve blockade in the groin with head-down positioning

Quality assurance in postoperative pain management by comparing PENG (pericapsular nerve group) blockade and a higher-volume PENG blockade with and without foot-down positioning in patients undergoing total hip arthroplasty (THA) under general anesthesia with lateral access, and a high-volume and low-concentration femoral nerve blockade in the groin with head-down positioning

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036841
Enrollment
250
Registered
2025-07-25
Start date
2025-07-28
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16

Interventions

Group 1: PENG with 20 ml Naropin 0.5% and multimodal analgesia Group 2: PENG with 30 ml Naropin 0.375% and multimodal analgesia Group 3: PENG with 30 ml Naropin 0.375% and multimodal analgesia and Foo

Sponsors

Katholisches Klinikum Bochum, Martin-Luther Krankenhaus
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • All patients undergoing total hip arthroplasty at the Martin Luther Hospital Bochum-Wattenscheid, part of the Catholic Hospital Bochum, between 2025 and 2026 • Anesthesia: General anesthesia • Surgical approach: Lateral approach • Ages 18 or older • ASA I-III • Patient consent

Exclusion criteria

Exclusion criteria: • Severe chronic pain syndrome • Under 18 years of age • Anesthesia technique: Spinal anesthesia • Surgical approach: No lateral approach • Pregnancy • Joint infection, such as periprosthetic joint infection (PJI) and history of PJI • ASA IV • Allergies to local anesthetics • Infection at the puncture site • Failure to sign a consent form and patient refusal • Dementia or inability to cooperate • Language barrier • Alcohol dependence

Design outcomes

Primary

MeasureTime frame
Cumulative amount of additional opioid analgesics administered up to the first postoperative day

Secondary

MeasureTime frame
• Time to first opioid in minutes • Pain intensity: Change in NRS pain score on the day of surgery (0-10) • Pain intensity: Change in NRS pain score on the first postoperative day (0-10) • Degree of quadriceps weakness after the block on the blocked and operated side, muscle strength assessment (Manual Muscle Test = MMT) • Time the patient first got out of bed • Duration of first getting out of bed • Time the patient first walked with a walking aid under the guidance of a rehabilitation physician and physiotherapist

Countries

Germany

Contacts

Public ContactAlexander Andres, MHBA

Katholisches Klinikum Bochum, Martin-Luther Krankenhaus

alexander.andres@klinikum-bochum.de+492327657300

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026